The relationship between erectile dysfunction and stroke risk is clinically important because an erection depends on healthy blood vessels, intact nerves, and responsive vascular tissue. When erectile function changes, especially without an obvious psychological or medication-related explanation, the symptom may reflect the same endothelial injury and atherosclerotic burden that contribute to cerebrovascular disease. Erectile dysfunction does not mean that a stroke is imminent, but it can provide an opportunity to identify modifiable cardiovascular risk earlier.
Why Erectile Dysfunction and Stroke Risk Share a Vascular Pathway
Normal erectile function begins with sexual stimulation, neural signaling, and the release of nitric oxide within penile tissue. Nitric oxide increases cyclic guanosine monophosphate, or cGMP, causing smooth muscle in the penile arteries and corpora cavernosa to relax. Blood inflow rises, venous outflow is temporarily restricted, and rigidity develops.
The endothelium, the thin cellular lining inside blood vessels, is central to this process. Hypertension, smoking, diabetes, elevated LDL cholesterol, chronic inflammation, and physical inactivity can reduce endothelial nitric oxide production. They can also promote arterial stiffness and atherosclerotic plaque. In the penis, impaired vasodilation may first appear as difficulty achieving or maintaining an erection. In the brain, progressive vascular disease raises the likelihood of ischemic stroke.
The penile arteries are only about 1 to 2 millimeters in diameter, smaller than many coronary and cerebral arteries. This “artery-size” concept helps explain why symptoms may appear in erectile tissue before a larger vascular bed produces an obvious clinical event. It does not establish that erectile dysfunction causes every subsequent cardiovascular event. Rather, both conditions may reveal a shared underlying vascular process.
Stroke itself is not one disease. Ischemic stroke occurs when a vessel supplying the brain is blocked, while hemorrhagic stroke results from bleeding into or around the brain. Most research connecting erectile dysfunction with future stroke has focused on ischemic mechanisms, including large-artery atherosclerosis and small-vessel disease.
What Recent Research Says About Erectile Dysfunction and Stroke Risk
A 2025 analysis by Zhang and colleagues combined US National Health and Nutrition Examination Survey data with Mendelian randomization, a genetic epidemiology method designed to test whether an association may be consistent with causality. Among 3,624 participants in the observational analysis, men who reported never being able to achieve and maintain an erection had higher odds of stroke after adjustment for measured covariates. The fully adjusted odds ratio was 2.42, although the confidence interval was wide at 1.20 to 4.91 [1].
The genetic portion of that study found smaller but statistically significant associations between genetic liability to erectile dysfunction and both large-artery and small-vessel stroke. These findings strengthen the biologic argument, but they do not prove that treating erectile dysfunction itself prevents stroke. Mendelian randomization relies on assumptions about the genetic instruments used, and the observational component cannot eliminate every source of confounding.
The broader epidemiologic record points in the same direction. A systematic review by Mostafaei and colleagues synthesized evidence across cardiovascular outcomes and reported that men with erectile dysfunction had a 36% higher relative risk of stroke than men without it. Increased risks were also observed for coronary heart disease, myocardial infarction, cardiovascular mortality, and all-cause mortality [2]. Relative risk should not be confused with absolute risk: the practical meaning for an individual depends heavily on age, blood pressure, diabetes status, smoking, cholesterol, family history, and prior cardiovascular disease.
Clinical consensus has evolved accordingly. The 2024 Princeton IV recommendations characterize predominantly vasculogenic erectile dysfunction as a cardiovascular risk marker and risk-enhancing factor. The panel recommends formal 10-year atherosclerotic cardiovascular disease risk assessment for men with likely vascular ED and consideration of coronary artery calcium scoring in selected men whose calculated risk does not fully explain the concern [3]. The purpose is not to turn every sexual symptom into an emergency. It is to avoid treating a potentially informative vascular signal as an isolated quality-of-life issue.
How Clinicians Distinguish Vascular ED From Other Causes
Erectile dysfunction can arise from multiple mechanisms, and many men have more than one contributor. A careful history usually examines onset, consistency, morning or sleep-related erections, sexual desire, relationship context, medication use, substance use, prior surgery, and neurologic symptoms.
Features that may support a vascular contribution include gradual progression, reduced rigidity across situations, loss of spontaneous erections, diabetes, hypertension, tobacco exposure, obesity, or known atherosclerotic disease. A sudden and situation-specific change with preserved morning erections may point more strongly toward performance anxiety or another psychogenic component, although this distinction is not absolute.
Medication review matters. Some antihypertensives, antidepressants, antiandrogens, and other drugs may affect erectile function, but prescribed medication should not be stopped without clinician guidance. Untreated high blood pressure usually presents a greater long-term vascular hazard than a medication side effect, and alternative agents may be available.
A typical evaluation may include blood pressure measurement, body mass index or waist circumference, fasting glucose or hemoglobin A1c, a lipid panel, and assessment of smoking and exercise. Testosterone testing may be appropriate when low libido, reduced morning erections, fatigue, infertility, or other signs of androgen deficiency are present. Additional cardiovascular testing is individualized rather than automatic.
Warning Signs That Require Prompt Medical Attention
Erectile dysfunction alone is generally evaluated through routine medical care, but symptoms of stroke require emergency action. Sudden facial drooping, weakness or numbness on one side, speech difficulty, confusion, vision loss, severe unexplained headache, dizziness, or loss of coordination should prompt immediate emergency services. Treatment effectiveness for ischemic stroke is highly time-dependent.
Men should also seek prompt assessment for chest pain, fainting, new shortness of breath, or marked exercise intolerance, especially if symptoms occur during sexual activity. Sexual activity generally represents modest physical exertion, but a person who cannot climb two flights of stairs without chest discomfort or disproportionate breathlessness may need cardiovascular evaluation before resuming sexual activity or starting treatment.
Prescription phosphodiesterase type 5 inhibitors can be appropriate for many men with stable cardiovascular disease under medical supervision. However, they must not be combined with nitrate medications such as nitroglycerin or isosorbide because the interaction can cause a dangerous fall in blood pressure. Riociguat is also contraindicated. Alpha-blockers, substantial alcohol intake, low baseline blood pressure, and some drug interactions require additional caution.
Reducing Shared Vascular Risk
The most useful response to a possible vascular warning sign is a structured risk review, not alarm. Blood pressure control, smoking cessation, diabetes management, treatment of elevated atherogenic cholesterol, regular physical activity, sufficient sleep, and a dietary pattern centered on minimally processed foods may support both vascular and erectile health.
Exercise can improve endothelial function, cardiorespiratory fitness, insulin sensitivity, and blood pressure. For most adults, public-health guidance supports at least 150 minutes of moderate-intensity aerobic activity each week plus resistance training on two or more days, adjusted for health status and physical capacity. Men with concerning cardiac symptoms should obtain medical clearance before beginning vigorous exercise.
Weight reduction may support erectile function in men with overweight or obesity, but the goal is metabolic improvement rather than rapid loss. Waist circumference, blood pressure, triglycerides, HDL cholesterol, and glucose control often provide more clinically useful information than body weight alone.
Treatment of erectile symptoms and reduction of vascular risk are complementary goals. A medication that supports penile blood flow does not remove atherosclerotic plaque, normalize untreated hypertension, or replace stroke prevention. Conversely, risk-factor improvement may support erectile response but does not guarantee that medication will be unnecessary. A physician can address both tracks at the same visit.
Conclusion
Erectile dysfunction and stroke risk are linked by endothelial dysfunction, atherosclerosis, hypertension, diabetes, smoking, and other vascular factors. Cohort evidence, meta-analyses, genetic epidemiology, and current expert guidance all support viewing new, persistent, or progressive erectile dysfunction as a reason to assess cardiovascular health. The association is a prompt for proportionate screening, not a prediction that a particular man will have a stroke.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans, including EPIQ CHEWS, starting with a free online assessment at questionnaire.getonyxmd.com. More evidence-focused men's health articles are available on the /blog.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Zhang B, Yang Q, Sun H, Liu M, Liang H, Ji H. Erectile dysfunction increases the risk of stroke: evidence from NHANES and Mendelian randomization analysis. Translational Andrology and Urology. 2025;14(10):3042-3052. doi:10.21037/tau-2025-396
Mostafaei H, Mori K, Hajebrahimi S, Abufaraj M, Karakiewicz PI, Shariat SF. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU International. 2021;128(1):3-11. doi:10.1111/bju.15313
Köhler TS, Kloner RA, Rosen RC, Burnett AL, Blaha MJ, Ganz P, et al. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings. 2024;99(9):1500-1517. doi:10.1016/j.mayocp.2024.06.002
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.